Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Is it possible to predict the degree of FVIII deficiency from APTT waveform analysis on Behring Coagulation Timer (BCT) (CROSBI ID 509369)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Miloš, Marija ; Coen, Desiree ; Zadro, Renata Is it possible to predict the degree of FVIII deficiency from APTT waveform analysis on Behring Coagulation Timer (BCT) // Journal of thrombosis and haemostasis / Mannucci, Pier M. (ur.). 2005

Podaci o odgovornosti

Miloš, Marija ; Coen, Desiree ; Zadro, Renata

engleski

Is it possible to predict the degree of FVIII deficiency from APTT waveform analysis on Behring Coagulation Timer (BCT)

With modern coagulation instruments, every aPTT result is not just a number but a collection of photo-optical data in the form of reaction curve. In this study we have performed a quantitative aPTT waveform analysis in order to examine whether it was possible to detect the degree of FVIII deficiency using parameters from this analysis. We measured aPTT (Actin FS, Dade Behring) in 38 normal and 87 hemophilia A patients on BCT coagulation analyzer (Dade Behring), with two different evaluation modes: fixed absorbance (FA) and point of inflexion (PI), that determine clotting times at the onset and midpoint of coagulation, respectively. Additionally, we calculated delta-aPTT (DaPTT) as aPTT-PI minus aPTT-FA and aPTT-slope ratio (aPTTSR) as ratio between DaPTT and aPTT-FA. FVIII activity was measured by one-stage assay. FVIII inhibitor screen was performed and inhibitor concentrations determined, when needed. Hemophilia patients were further divided in 4 groups (H1-H4) according to FVIII activity, and into 2 groups according to the presence (I2) or absence (I1) of the inhibitor. Significant differences (p<0.05) were found in DaPTT and aPTTSR values between normal and hemophilia patients, as well as between H1 to H4 and I1 and I2 groups. In normal and hemophilia patients the obtained results (mean± ; SD) for DaPTT were 4.24± ; 1.11 and 20.03± ; 11.47, respectively, and for aPTTSR 0.16± ; 0.03 and 0.33± ; 0.14, respectively. Results in specific groups were as follows: group H1 (N=41, FVIII<0.01) DaPTT=29.48± ; 8.62, aPTTSR=0.44± ; 0.13 ; group H2 (N=12, FVIII=0.01-0.05) DaPTT=17.51± ; 5.87, aPTTSR=0.29± ; 0.09 ; group H3 (N=24, FVIII=0.05-0.30) DaPTT=10.25± ; 4.18, aPTTSR=0.23± ; 0.05 ; group H4 (N=10, FVIII=0.30-0.50) DaPTT=7.75± ; 1.19, aPTTSR=0.19± ; 0.04 ; group I1 (N=48) DaPTT=17.83± ; 12.19, aPTTSR=0.30± ; 0.14, group I2 (N=21) DaPTT=28.06± ; 6.61, aPTTSR=0.42± ; 0.13. Based on these results, DaPTT values >6.5 and >17.7 allowed distinguishing between normal and hemophilia patients (sensitivity 94.7%, specificity 100%), and between patients with and without inhibitors (sensitivity 95.5%, specificity 64.7%), respectively.

FVIII deficiency; inhibitors; waveform analysis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2005.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Journal of thrombosis and haemostasis

Mannucci, Pier M.

Wiley-Blackwell

1538-7933

Podaci o skupu

Congress International Society on Thrombosis and Haemostasis (20 ; 2005)

poster

06.08.2005-12.08.2005

Sydney, Australija

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost